PUBLIC CONTRACT · 2023
Vários Medicamentos
- Contract value
- €685,492.31
- Signed on
- 15 March 2023
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 9878789PUBLISHED DESCRIPTION
61004223 - AQ Urgente Medicamentos por adudicar concursos Centralizados
Parties involved
- Awardee
- Boehringer Ingelheim Portugal; JABA RECORDATI, SA.; ACCORD HEALTHCARE , UNIPESSOAL LDA; ZAMBON - PRODUTOS FARMACEUTICOS, LDA; SANDOZ FARMACÊUTICA, LDA.; LEO FARMACÊUTICOS, LIMITADA; PHARMAKERN PORTUGAL, LDA.; TEVA-PHARMA - PRODUTOS FARMACÊUTICOS, LDA.; GLAXOSMITHKLINE-PROD. FARMACÊUTICOS, LDA.; CSL BEHRING; GENERIS-FARMACEUTICA, S.A.; MERCK SHARP DOHME; JANSSEN CILAG FARMACEUTICA, LDA; LAB. PFIZER, LDA.; BAXTER MEDICO - FARMACEUTICA, LDA; NOVARTIS FARMA-PRODUT.FARMACEUTICOS, SA; TAKEDA FARMACEUTICOS PORTUGAL, LDA (SHIRE); ALLOGA PORTUGAL - ARMAZ. E DIST. FAR.(CANCELADA); BIOGEN PORTUGAL, SOC FARMACÊUTICA, UNIPESSOAL; MEDAC; GILEAD SCIENCES LDA.; ROCHE FARMACÊUTICA QUIMICA, LDA.; ASTELLAS FARMA, LDA.; FRESENIUS KABI PHARMA PORTUGAL; VIV HEALTHCARE, UNIPESSOAL, LDA; BRISTOL - MYERS SQUIBB SA.; MYLAN, LDA.
- Place of performance
- Portugal, Setúbal, Setúbal
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- Boehringer Ingelheim Portugal · Tax ID 500537410
- Awardee
- JABA RECORDATI, SA. · Tax ID 500492867
- Awardee
- ACCORD HEALTHCARE , UNIPESSOAL LDA · Tax ID 508622263
- Awardee
- ZAMBON - PRODUTOS FARMACEUTICOS, LDA · Tax ID 502155930
- Awardee
- SANDOZ FARMACÊUTICA, LDA. · Tax ID 506985261
- Awardee
- LEO FARMACÊUTICOS, LIMITADA · Tax ID 503932680
- Awardee
- PHARMAKERN PORTUGAL, LDA. · Tax ID 507002571
- Awardee
- TEVA-PHARMA - PRODUTOS FARMACÊUTICOS, LDA. · Tax ID 507045491
- Awardee
- GLAXOSMITHKLINE-PROD. FARMACÊUTICOS, LDA. · Tax ID 500139962
- Awardee
- CSL BEHRING · Tax ID 503047201
- Awardee
- GENERIS-FARMACEUTICA, S.A. · Tax ID 508107997
- Awardee
- MERCK SHARP DOHME · Tax ID 500191360
- Awardee
- JANSSEN CILAG FARMACEUTICA, LDA · Tax ID 500189412
- Awardee
- LAB. PFIZER, LDA. · Tax ID 500162166
- Awardee
- BAXTER MEDICO - FARMACEUTICA, LDA · Tax ID 503347345
- Awardee
- NOVARTIS FARMA-PRODUT.FARMACEUTICOS, SA · Tax ID 500063524
- Awardee
- TAKEDA FARMACEUTICOS PORTUGAL, LDA (SHIRE) · Tax ID 502801204
- Awardee
- ALLOGA PORTUGAL - ARMAZ. E DIST. FAR.(CANCELADA) · Tax ID 504507230
- Awardee
- BIOGEN PORTUGAL, SOC FARMACÊUTICA, UNIPESSOAL · Tax ID 506415740
- Awardee
- MEDAC · Tax ID 980369959
- Awardee
- GILEAD SCIENCES LDA. · Tax ID 503604704
- Awardee
- ROCHE FARMACÊUTICA QUIMICA, LDA. · Tax ID 500233810
- Awardee
- ASTELLAS FARMA, LDA. · Tax ID 502540249
- Awardee
- FRESENIUS KABI PHARMA PORTUGAL · Tax ID 504293753
- Awardee
- VIV HEALTHCARE, UNIPESSOAL, LDA · Tax ID 509117961
- Awardee
- BRISTOL - MYERS SQUIBB SA. · Tax ID 500048193
- Awardee
- MYLAN, LDA. · Tax ID 502248793
Matches in the records
- MYLAN, LDA. and CSL BEHRING share an address · Source: TED (Jornal Oficial da UE), aviso 637400-2025 · Source: TED (Jornal Oficial da UE), aviso 604352-2025
Address and group matches come from the records cited and say only what those records show.
Values and timeline
- Contract price
- €685,492.31
- Procedure base price
- €685,492.31
- Total effective price
- Not reported on Portal BASE
- Publication date
- 23 March 2023
- Award date
- 15 March 2023
- Signing date
- 15 March 2023
- Performance period
- 12 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Monofator
- CPV code
- 33000000-0 - Equipamento médico, medicamentos e produtos para cuidados pessoais
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos ( DL 111-B/2017 )
- Framework agreement
- CP 2022/40 - Medicamentos antirretrovíricos para o tratamento da infeção por VIH
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 6408141
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.